Minerva Neurosciences, Inc.

NASDAQ:NERV

Biotechnology

Healthcare
$2.16 -6.49%

-$0.30 today

Market cap
$107.64M
Beta
-0.11
P/E (TTM)
-0.2
EPS (TTM)
-$8.46
52W Low $1.76High $12.46

Volume 0.15M

Average 0.21M

Price history

Minerva Neurosciences, Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

-49.77%

Period high

$8.07

Period low

$2.16

Latest

$2.16

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
8-KNov 6, 2026Nov 6, 2026
10-QNov 6, 2026Nov 6, 2026
4Nov 3, 2026Nov 3, 2026
SC 13GOct 27, 2026Oct 27, 2026
3Aug 20, 2026Aug 20, 2026
3Aug 20, 2026Aug 20, 2026
SC 13G/AAug 14, 2026Aug 14, 2026
SC 13G/AAug 13, 2026Aug 13, 2026
8-KAug 12, 2026Aug 12, 2026
10-QAug 7, 2026Aug 7, 2026
8-KAug 7, 2026Aug 7, 2026
4Aug 3, 2026Aug 3, 2026
SC 13G/AJul 8, 2026Jul 8, 2026
4Jun 5, 2026Jun 5, 2026

Competitors

Who does Minerva Neurosciences, Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about NERV's filings, answered from its disclosures.

What is the latest NERV filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does NERV have?

Intrinsic Alpha currently shows 20 recent filings for NERV.